Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Raizer

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Neuro-Oncology Practice|June 3, 2015
Financial burden experienced by patients undergoing treatment for malignant gliomasPriya Kumthekar, Becky V Stell, Daniel I Jacobs, et al.
Cancer|December 20, 2011
Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphomaJeffrey J Raizer, Alfred Rademaker, Andrew M Evens, et al.
Journal of Neuro-Oncology|August 10, 2012
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomasSean A Grimm, Maryanne Marymont, James P Chandler, et al.
Journal of Neuro-Oncology|July 21, 2009
Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literatureRoneil G Malkani, Martin Tallman, Numa Gottardi-Littell, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Journal of Neuro-Oncology|June 15, 2016
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomasJeffrey J Raizer, James P Chandler, Roberto Ferrarese, et al.
Journal of Neuro-Oncology|January 29, 2013
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastasesPriya Kumthekar, Sean A Grimm, Michael J Avram, et al.
Neuro-Oncology|July 30, 2011
Gene-protein correlation in single cellsJaclyn J Renfrow, Adrienne C Scheck, Neil S Dhawan, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Neuro-Oncology Practice|June 3, 2015
Financial burden experienced by patients undergoing treatment for malignant gliomasPriya Kumthekar, Becky V Stell, Daniel I Jacobs, et al.
Cancer|December 20, 2011
Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphomaJeffrey J Raizer, Alfred Rademaker, Andrew M Evens, et al.
Journal of Neuro-Oncology|August 10, 2012
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomasSean A Grimm, Maryanne Marymont, James P Chandler, et al.
Journal of Neuro-Oncology|July 21, 2009
Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literatureRoneil G Malkani, Martin Tallman, Numa Gottardi-Littell, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Journal of Neuro-Oncology|June 15, 2016
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomasJeffrey J Raizer, James P Chandler, Roberto Ferrarese, et al.
Journal of Neuro-Oncology|January 29, 2013
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastasesPriya Kumthekar, Sean A Grimm, Michael J Avram, et al.
Neuro-Oncology|July 30, 2011
Gene-protein correlation in single cellsJaclyn J Renfrow, Adrienne C Scheck, Neil S Dhawan, et al.
Pageof 8